1. ZHAW digitalcollection
  2. Gesundheit
  3. Publikationen
  4. Publikationen Gesundheit
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTeuwen, Max M H-
dc.contributor.authorVliet Vlieland, Thea P.M.-
dc.contributor.authorvan Weely, Salima F.E.-
dc.contributor.authorSchoones, Jan W.-
dc.contributor.authorRausch, Anne-Kathrin-
dc.contributor.authorJuhl, Carsten B.-
dc.contributor.authorNiedermann Schneider, Karin-
dc.contributor.authorGademan, Maaike G.J.-
dc.contributor.authorvan den Ende, Cornelia H.M.-
dc.date.accessioned2024-01-19T10:23:02Z-
dc.date.available2024-01-19T10:23:02Z-
dc.date.issued2024-01-
dc.identifier.issn0172-8172de_CH
dc.identifier.issn1437-160Xde_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/29634-
dc.description.abstractTo describe the quality of reporting and the nature of reported harms in clinical studies on the effectiveness of supervised exercises in patients with rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA). We performed a systematic review, searching eight databases up to February 2023. Randomized controlled trials (RCTs) evaluating supervised exercises in adults with RA or axSpA were considered eligible. Data on harms were extracted according to the CONSORT Harms 2022 Checklist. Among others, it was recorded if harms were prespecified or non-prespecified. Moreover, the nature of reported harms was listed. Forty RCTs were included for RA and 25 for axSpA, of which 29 (73%) and 13 (52%) reported information on harms. In 13 (33%) RCTs in RA and four (16%) in axSpA, the collection of harms outcomes was described in the methods section. Prespecified outcomes were reported by eight (RA) and two (axSpA) RCTs. Non-specified harms outcomes were reported by six (RA) and four (axSpA) RCTs. Prespecified harms outcomes included measures of pain, disease activity, inflammation, and structural joint changes. The nature of non-prespecified harms outcomes varied largely, with pain being most common. A considerable proportion of trials on supervised exercise in RA or axSpA does not or inadequately report harms outcomes. Pain was the most commonly reported prespecified or non-specified harm. For a considerate interpretation of the balance between benefits and harms of supervised exercise in RA or axSpA, use of the CONSORT Harms 2022 Checklist for the design, conduct and reporting of trials is advocated.de_CH
dc.language.isoende_CH
dc.publisherSpringerde_CH
dc.relation.ispartofRheumatology Internationalde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subjectAxial spondyloarthritisde_CH
dc.subjectExercise therapyde_CH
dc.subjectRheumatoid arthritisde_CH
dc.subjectSafetyde_CH
dc.subjectSystematic reviewde_CH
dc.subjectAdultde_CH
dc.subjectHumansde_CH
dc.subjectPainde_CH
dc.subjectArthritis, Rheumatoidde_CH
dc.subject.ddc616.7: Krankheiten des Bewegungsapparates und Orthopädiede_CH
dc.titleQuality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritisde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementGesundheitde_CH
zhaw.organisationalunitInstitut für Physiotherapie (IPT)de_CH
dc.identifier.doi10.1007/s00296-023-05502-3de_CH
dc.identifier.pmid38030947de_CH
zhaw.funding.euNode_CH
zhaw.issue1de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end39de_CH
zhaw.pages.start25de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume44de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedG: IPT: Interventionde_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Gesundheit

Files in This Item:
There are no files associated with this item.
Show simple item record
Teuwen, M. M. H., Vliet Vlieland, T. P. M., van Weely, S. F. E., Schoones, J. W., Rausch, A.-K., Juhl, C. B., Niedermann Schneider, K., Gademan, M. G. J., & van den Ende, C. H. M. (2024). Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis. Rheumatology International, 44(1), 25–39. https://doi.org/10.1007/s00296-023-05502-3
Teuwen, M.M.H. et al. (2024) ‘Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis’, Rheumatology International, 44(1), pp. 25–39. Available at: https://doi.org/10.1007/s00296-023-05502-3.
M. M. H. Teuwen et al., “Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis,” Rheumatology International, vol. 44, no. 1, pp. 25–39, Jan. 2024, doi: 10.1007/s00296-023-05502-3.
TEUWEN, Max M H, Thea P.M. VLIET VLIELAND, Salima F.E. VAN WEELY, Jan W. SCHOONES, Anne-Kathrin RAUSCH, Carsten B. JUHL, Karin NIEDERMANN SCHNEIDER, Maaike G.J. GADEMAN und Cornelia H.M. VAN DEN ENDE, 2024. Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis. Rheumatology International. Januar 2024. Bd. 44, Nr. 1, S. 25–39. DOI 10.1007/s00296-023-05502-3
Teuwen, Max M H, Thea P.M. Vliet Vlieland, Salima F.E. van Weely, Jan W. Schoones, Anne-Kathrin Rausch, Carsten B. Juhl, Karin Niedermann Schneider, Maaike G.J. Gademan, and Cornelia H.M. van den Ende. 2024. “Quality of Reporting and Nature of Harms in Clinical Trials on Supervised Exercise in Patients with Rheumatoid Arthritis or Axial Spondyloarthritis.” Rheumatology International 44 (1): 25–39. https://doi.org/10.1007/s00296-023-05502-3.
Teuwen, Max M. H., et al. “Quality of Reporting and Nature of Harms in Clinical Trials on Supervised Exercise in Patients with Rheumatoid Arthritis or Axial Spondyloarthritis.” Rheumatology International, vol. 44, no. 1, Jan. 2024, pp. 25–39, https://doi.org/10.1007/s00296-023-05502-3.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.